Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 May 2;23(1):147.
doi: 10.1186/s12871-023-02104-1.

Comparison of the recovery profile of remimazolam with flumazenil and propofol anesthesia for open thyroidectomy

Affiliations
Randomized Controlled Trial

Comparison of the recovery profile of remimazolam with flumazenil and propofol anesthesia for open thyroidectomy

Ho-Jin Lee et al. BMC Anesthesiol. .

Abstract

Background: Previous studies have consistently reported a slower recovery of consciousness following remimazolam-based total intravenous anesthesia without flumazenil than with propofol. This study aimed to compare the reversal effect of flumazenil on the recovery of consciousness after remimazolam-based total intravenous anesthesia with the propofol recovery profile.

Methods: This prospective, single-blinded, randomized trial included 57 patients undergoing elective open thyroidectomy at a tertiary university hospital. Patients were randomly allocated to receive either remimazolam- or propofol-based total intravenous anesthesia (remimazolam group: 28 patients, propofol group: 29 patients). The primary outcome was the time from the end of general anesthesia to first eye opening (min). The secondary outcomes were the time from the end of the general anesthesia to extubation (min), initial modified Aldrete score measured at the post-anesthesia care unit, length of stay at the post-anesthesia care unit (min), occurrence of postoperative nausea and vomiting during the first 24 h postoperatively, and Korean version of Quality of Recovery-15 score at 24 h postoperatively.

Results: The remimazolam group showed significantly faster first eye opening time (2.3 [interquartile range, IQR: 1.8-3.3] min vs. 5.0 [IQR: 3.5-7.8] min, median difference:-2.7 [95% confidence interval, CI: -3.7 to -1.5] min, P < 0.001) and extubation time (3.2 [IQR: 2.4-4.2] min vs. 5.7 [IQR: 4.7-8.3] min, median difference: -2.7 [97.5% CI: -5.0 to -1.6] min, P < 0.001). There were no significant differences in other postoperative outcomes.

Conclusions: The planned incorporation of flumazenil with remimazolam-based total intravenous anesthesia provided rapid and reliable recovery of consciousness.

Trial registration: ClinicalTrials.gov NCT05047939.

Keywords: Benzodiazepines; Delayed emergence from anesthesia; Flumazenil; General anesthetics; Intravenous anesthesia.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
CONSORT diagram of patient recruitment
Fig. 2
Fig. 2
Between group comparisons of the time from the end of the general anesthesia to first eye opening (A) and extubation (B). The box plot shows the median and interquartile range of time in the remimazolam (n = 28) and propofol (n = 29) groups. Upper and lower whiskers are maximum and minimum values excluding outliers, respectively. The scatter plot (round symbols) shows the individual data points. The violin plot shows the distribution of the data points for each group. The width of each violin represents the density of the data points. **Adjusted P < 0.01, ***Adjusted P < 0.001

Similar articles

Cited by

References

    1. Kim KM. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Anesth Pain Med (Seoul) 2022;17:1–11. doi: 10.17085/apm.21115. - DOI - PMC - PubMed
    1. Wesolowski AM, Zaccagnino MP, Malapero RJ, Kaye AD, Urman RD. Remimazolam: pharmacologic considerations and clinical role in anesthesiology. Pharmacotherapy. 2016;36:1021–1027. doi: 10.1002/phar.1806. - DOI - PubMed
    1. Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020;34:543–53. doi: 10.1007/s00540-020-02788-6. - DOI - PubMed
    1. Shimamoto Y, Sanuki M, Kurita S, Ueki M, Kuwahara Y, Matsumoto A. Factors affecting prolonged time to extubation in patients given remimazolam. PLoS ONE. 2022;17:e0268568. doi: 10.1371/journal.pone.0268568. - DOI - PMC - PubMed
    1. Dexter F, Bayman EO, Epstein RH. Statistical modeling of average and variability of time to extubation for meta-analysis comparing desflurane to sevoflurane. Anesth Analg. 2010;110:570–580. doi: 10.1213/ANE.0b013e3181b5dcb7. - DOI - PubMed

Publication types

Associated data